TY  - JOUR
T1  - A Reason of Facial Diplegia: GuillainBarré Syndrome
AU  - Arıkan, Zehra
AU  - Akyol, Ali
AU  - Kıylıoğlu, Nefati
PY  - 2020
DA  - August
DO  - 10.4274/meandros.galenos.2017.30502
JF  - Meandros Medical And Dental Journal
JO  - Meandros Med. Den. j.
PB  - Aydin Adnan Menderes University
WT  - DergiPark
SN  - 2149-9063
SP  - 163
EP  - 166
VL  - 21
IS  - 2
LA  - en
AB  - Guillain-Barré syndrome (GBS), an acute demyelinating inflammatory poliradiculopathy, is characterised by rapidly progressive, symmetrical, ascending weakness and areflexia. The disease usually occurs after 1-3 weeks of infection, vaccinations, trauma, surgical interventions and immunosuppression. Facial diplegia and paraesthesia which is a rare GBS variant has no weakness whereas, GBS is present with weakness which usually begins from lower extremities. In this article, three cases were presented to emphasise the importance of GBS in patients with facial diplegia.
KW  - Facial diplegia
KW  - Guillain-Barré syndrome
KW  - paraesthesia
CR  - 1. Visser LH, van der Meche FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, et al. Cytomegalovirus infection and Guillain-Barré syndrome: The clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group. Neurology 1996; 47: 668-73.
CR  - 2. Akarsu EO, Yalçın D, Sürmeli R, Demir A, Sünter G, Diler Y. A Rare Variant of Guillain-Barre Syndrome: Facial Diplegia Paresthesia. Turk J Neurol 2015; 21: 171-4.
CR  - 3. Cros D, Triggs WJ. Guillain Barre syndrome: clinical neurophysiologic studies. Rev Neurol (Paris) 1996; 152: 339-43.
CR  - 4. Brannagan TH 3rd. Intravenous gammaglobulin for treatment of CIDP and related immune-mediated neuropathies. Neurology 2002; 59: S33-40.
CR  - 5. Bradley Walter G. Neurology in Clinical Practice Guillain Barre Syndrome 2012; S2288-96.
UR  - https://doi.org/10.4274/meandros.galenos.2017.30502
L1  - https://dergipark.org.tr/en/download/article-file/4933502
ER  -